(Circulation. 1996;94:234-235.)
© 1996 American Heart Association, Inc.
Articles |
the National Heart, Lung, and Blood Institute, Bethesda, Md.
Correspondence to Claude Lenfant, MD, National Heart, Lung, and Blood Institute, Bldg 31, Room 5A52, 31 Center Dr, MSC 2486, Bethesda, MD 20892. (Circulation. 1996;94:234-235.)
| Introduction |
|---|
Report language accompanying theFY 1996 NIH Appropriations Bill
With its generous increase in funding for the National Institutes of Health (NIH) and the National Heart, Lung, and Blood Institute (NHLBI) in a year when competition for federal resources was especially keen, the US Congress made clear its continued support for the biomedical research enterprise. However, by accompanying the legislation with the above language, it also offered some pointed advice to the NIH and to the entire biomedical community: It pays to advertise.
Congress is as aware as we are of the benefits of biomedical research, but it is also aware that the public often knows nothing of the implications of scientific advances or the source of their funding. That's where you come in. You must do a better job of publicizing your research results and explaining their benefits in terms that the public can appreciate. You also must make every effort, at every opportunity, to acknowledge the source of funding for your research.
Despite tireless advocacy for federally funded biomedical research by individuals such as Representative
This article has been cited by other articles:
![]() |
D. S. Winlaw Angiogenesis in the Pathobiology and Treatment of Vascular and Malignant Diseases Ann. Thorac. Surg., October 1, 1997; 64(4): 1204 - 1211. [Abstract] [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1996 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |